GC26334
SRI 37892
Also known as 4-(benzimidazol-1-yl)-N-[4-(2-oxo-3,4-dihydro-1H-quinolin-6-yl)-1,3-thiazol-2-yl]benzamide
SRI 37892 is a small molecule compound inhibitor of Frizzled protein 7 (Fzd7) with inhibitory activity against cancer cell proliferation (IC502μM)
ChemicalCAS1030769-75-5MW465.53FormulaC26H19N5O2S
- CAS number
- 1030769-75-5
- Molecular weight
- 465.53
- Formula
- C26H19N5O2S
- InChIKey
- DXSMYUKZPWJQFM-UHFFFAOYSA-N
- Catalogue number
- GC26334
- Brand
- GLPBIO
Computed properties PubChem CID 41550022 · XLogP 4.1 · TPSA 117 Ų · H-bond donors 2
- XLogP
- 4.1
- TPSA
- 117 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 34
SMILES C1CC(=O)NC2=C1C=C(C=C2)C3=CSC(=N3)NC(=O)C4=CC=C(C=C4)N5C=NC6=CC=CC=C65
Computed descriptors from PubChem (CID 41550022), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il